Notice is hereby given that the Office of Research Integrity (ORI) has made final findings of scientific misconduct in the following case: Barbara Jones, St. Mary's Hospital, Montreal: The Office of Research Integrity (ORI) conducted an investigation into possible scientific misconduct on the part of Ms. Barbara Jones while a data coordinator at St. Mary's Hospital, Montreal, Quebec. ORI concluded that Ms. Jones committed scientific misconduct by falsifying and fabricating the dates of tests or examinations required prior to study entry for two women entered on the Breast Cancer Prevention Trial (BCPT). The BCPT is coordinated by the National Surgical Adjuvant Breast and Bowel Project (NSABP) and supported by the National Cancer Institute and the National Heart, Lung, and Blood Institute. Because the BCPT is still in progress, no conclusions or results have been published and no clinical recommendations have been based on the results of the study. Ms. Jones did not contest the ORI findings or administrative actions which require that, for a period of three years, any institution which proposes Ms. Jones' participation in PHS-supported research must submit a supervisory plan designed to ensure the scientific integrity of her contribution. Ms. Jones is also prohibited from serving in any advisory capacity to the PHS for a period of three years.
